RU93053041A - KIDNEY DIAGNOSTIC TOOL CONTAINING FRUCTAN - Google Patents

KIDNEY DIAGNOSTIC TOOL CONTAINING FRUCTAN

Info

Publication number
RU93053041A
RU93053041A RU93053041/14A RU93053041A RU93053041A RU 93053041 A RU93053041 A RU 93053041A RU 93053041/14 A RU93053041/14 A RU 93053041/14A RU 93053041 A RU93053041 A RU 93053041A RU 93053041 A RU93053041 A RU 93053041A
Authority
RU
Russia
Prior art keywords
fructan
diagnostic tool
tool containing
osmoticity
ultrafiltration
Prior art date
Application number
RU93053041/14A
Other languages
Russian (ru)
Other versions
RU2095076C1 (en
Inventor
Нич Эрнст
Original Assignee
Левозан ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4101910A external-priority patent/DE4101910A1/en
Application filed by Левозан ГмбХ filed Critical Левозан ГмбХ
Publication of RU93053041A publication Critical patent/RU93053041A/en
Application granted granted Critical
Publication of RU2095076C1 publication Critical patent/RU2095076C1/en

Links

Claims (1)

Почечное диагностическое средство содержит фруктан, причем водный экстракт фруктана, получаемый из частей растений, подвергают ультрафильтрации через первую мембрану, которая удерживает углеводы и протеины с более высокой молекулярной массой, однако пропускает фруктан. Полученный таким образом фильтрат подвергают второй ультрафильтрации через мембрану, удерживающую фруктан, но пропускающую соли и низкомолекулярные вещества, такие как моно- и олигосахариды. Полученный таким образом фруктан применяют как почечное диагностическое средство вместе с физиологически совместимыми буферными веществами с осмотичностью, которая соответствует осмотичности крови и имеет величину рН от 5,0 до 7,0.The renal diagnostic tool contains fructan, and fructan aqueous extract, obtained from plant parts, is subjected to ultrafiltration through the first membrane, which holds carbohydrates and proteins with higher molecular weight, but lets fructan pass. The filtrate thus obtained is subjected to a second ultrafiltration through a membrane that retains fructan, but permits salts and low molecular weight substances, such as mono- and oligosaccharides. The fructan obtained in this way is used as a renal diagnostic tool together with physiologically compatible buffer substances with an osmoticity which corresponds to the osmoticity of the blood and has a pH value of 5.0 to 7.0.
RU9293053041A 1991-01-23 1992-01-21 Method of preparing renal diagnostic agent used parenterally RU2095076C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4101910A DE4101910A1 (en) 1991-01-23 1991-01-23 METHOD FOR PRODUCING A PYROGEN-FREE GOOD WATER-SOLUBLE FRUCTAN AND A KIDNEY DIAGNOSTIC THAT CONTAINS SUCH A FRUCTAN
DEP4101910.5 1991-01-23
PCT/EP1992/000120 WO1992013005A1 (en) 1991-01-23 1992-01-21 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function

Publications (2)

Publication Number Publication Date
RU93053041A true RU93053041A (en) 1996-03-20
RU2095076C1 RU2095076C1 (en) 1997-11-10

Family

ID=6423545

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9293053041A RU2095076C1 (en) 1991-01-23 1992-01-21 Method of preparing renal diagnostic agent used parenterally

Country Status (18)

Country Link
US (1) US5561226A (en)
EP (1) EP0568574B1 (en)
JP (1) JPH06506236A (en)
AT (1) ATE151437T1 (en)
AU (1) AU1170392A (en)
CA (1) CA2101267C (en)
CZ (1) CZ284739B6 (en)
DE (2) DE4101910A1 (en)
DK (1) DK0568574T3 (en)
ES (1) ES2102491T3 (en)
FI (1) FI933301A (en)
HR (1) HRP940725A2 (en)
HU (1) HUT64778A (en)
NO (1) NO932652L (en)
RU (1) RU2095076C1 (en)
SI (1) SI9210024B (en)
WO (1) WO1992013005A1 (en)
YU (1) YU2492A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008498A3 (en) * 1994-07-07 1996-05-07 Tiense Suikerraffinaderij Nv Fractionated poly disperse structures
DE69512071T3 (en) * 1994-07-07 2005-10-20 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) FRACTIONATED POLYDISPERSE COMPOSITIONS
ATE429212T1 (en) * 1995-12-26 2009-05-15 Cns Inc INULIN DIET FIBER ADMINISTRATION SYSTEM
US5968365A (en) * 1996-02-05 1999-10-19 Mcneil-Ppc, Inc. Preparation of inulin products
US7057033B2 (en) 1997-05-27 2006-06-06 Tiense Suikerrafinaderij N.V. Fractionated polydisperse compositions
US6569488B2 (en) 1998-08-27 2003-05-27 Barnard Stewart Silver Processes for making novel inulin products
US6419978B1 (en) 1998-08-27 2002-07-16 Barnard Stewart Silver Inulin fractions
US6399142B1 (en) 1998-08-27 2002-06-04 Barnard Stewart Silver Liquid food products
US7045166B2 (en) * 1998-08-27 2006-05-16 Silver Barnard S Sweetener compositions containing fractions of inulin
DE10023051B4 (en) * 2000-05-11 2004-02-19 Roche Diagnostics Gmbh Process for the preparation of fluorescein isothiocyanate sinistrin, its use and diagnostic preparation containing fluorescein isothiocyanate sinistrin
DE102004045748A1 (en) * 2004-09-21 2006-04-06 Roche Diagnostics Gmbh Stoichiometrically defined dye-labeled substances for measuring the glomerular filtration rate, their preparation and use
US10150819B2 (en) 2008-04-23 2018-12-11 Tiense Suikerraffinaderij N.V. Aqueous dispersion of fructan-containing particles, method of preparation and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT304769B (en) * 1970-12-09 1973-01-25 Laevosan Gmbh & Co Kg Kidney function diagnostic and process for its production
US4198401A (en) * 1976-12-30 1980-04-15 Pegel Karl H Active plant extracts of hypoxidaceae and their use
CA1170203A (en) * 1981-09-15 1984-07-03 Ernst Hoehn Fructose syrup manufacture
JPS60160893A (en) * 1984-01-30 1985-08-22 Mitsui Toatsu Chem Inc Method to prepare improved purified fructan solution
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4900722A (en) * 1985-08-19 1990-02-13 Bioglucans, L.P. Methods and compositions for prophylactic and therapeutic treatment of infections
JPH0725683B2 (en) * 1985-10-31 1995-03-22 ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− Immunotherapy method
ES2066928T3 (en) * 1990-10-04 1995-03-16 Laevosan Gmbh & Co Kg LACTOSE PREPARATION AND PROCEDURE FOR ITS OBTAINING.

Similar Documents

Publication Publication Date Title
RU93053041A (en) KIDNEY DIAGNOSTIC TOOL CONTAINING FRUCTAN
DE68915715T2 (en) Membrane blood oxygenator.
ES2019400B3 (en) SEMIPERMEABLE, SEPARABLE AND HYDROPHILIC MEMBRANES BASED ON VINYLIDENE POLYFLUORIDE.
Craig Differential Dialysis: Molecular size and structure can be correlated with diffusion rates through calibrated dialysis membranes.
WO2004024300A8 (en) Ultrafiltration membrane, device, bioartificial organ and methods
DE69621819T2 (en) BIOCOMPATIBLE AQUEOUS SOLUTION FOR USE IN CONTINUOUS AMBULANT PERITONEAL DIALYSIS
DE68916816T2 (en) Air-dried cellulose acetate membranes.
DK185587A (en) MICROPOROUS ULTRAFILTRATION MEMBRANE
SE8502757D0 (en) DIALYSIS CONTROL SYSTEM
CA2101267A1 (en) Process for the production of a pyrogen-free fructan which is readily water-soluble as well as renal diagnostic agent containing such a fructan
DE3851367D1 (en) Ammonia separation using semipermeable membranes.
DE3779412D1 (en) FILTER MEMBRANES.
ATE119427T1 (en) TUBULAR MEMBRANE MODULE.
ATE102502T1 (en) IMPROVEMENTS TO MEMBRANE FILTERS FOR ULTRA OR MICROFILTRATION OF LIQUIDS, ESPECIALLY WATER.
EP1025762A3 (en) Milk calcium composition
Feldhoff et al. Effect of plasma proteins on the sieving spectra of hemofilters
IT1226072B (en) READY TO USE INJECTABLE SOLUTIONS CONTAINING AN ANTI-CYCLINIC ANTI-TUMORAL GLYCOSIDE.
EP0327005A1 (en) Process for extracorporeal treatment of ascitic fluid
ES8201595A1 (en) Process for the purification of glucosaminoglucans
JPS6475015A (en) Filter for separating leukocytes
KR920006008A (en) Preparation method of bone formation promoting substance
Dunstone Fractionation in a density gradient of some glycoproteins from human ovarian cyst fluids
Mylius et al. Capillary Membranes for Hemofiltration
RU93004691A (en) METHOD FOR DETERMINING THE CONTENT OF HEMOGLOBIN DERIVATIVE
SE8404355D0 (en) Reagents for determination of thrombocytes and leukocyte counts